Summary & Overview
HCPCS C1889: Implantable/Insertable Device, Not Otherwise Classified
HCPCS Level II code C1889 designates an implantable/insertable device, not otherwise classified. Nationally, this catch-all device code matters because it captures devices that lack a specific HCPCS Level II identifier, affecting coding clarity, claims processing, and device tracking across payers. Analysts and billing teams use it when manufacturers or existing code sets have not assigned a distinct code.
Key payers reviewed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how C1889 is used in practice, common sites of service where the code appears, and the implications for national billing workflows. The publication also summarizes benchmarks and policy context where available, highlights reimbursement considerations tied to non-specific device coding, and outlines typical documentation and clinical contexts that lead to use of an unclassified implantable device code.
This summary provides clinicians, billing professionals, and policy stakeholders with an operational view of C1889’s role in device reporting, claims adjudication, and program-level monitoring when a specific HCPCS Level II code is not applicable.
Billing Code Overview
HCPCS Level II code C1889 is defined as implantable/insertable device, not otherwise classified. This code is used to report an implantable or insertable medical device that does not have a more specific HCPCS Level II code assignment.
-
Service type: Implantable or insertable medical device placement or supply
-
Typical site of service: Ambulatory surgical center, hospital inpatient, hospital outpatient department, or other procedural settings where implantable devices are placed or provided
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with advanced peripheral arterial disease and chronic limb ischemia undergoes placement of an implantable vascular flow sensor device to monitor graft patency and hemodynamics. The device implanted is not described by a specific HCPCS Level II code and is therefore billed using C1889 (Implantable/insertable device, not otherwise classified). The clinical workflow includes pre-procedure evaluation (vascular imaging, medical optimization), informed consent for an investigational or device-specific implant, sterile implantation in an operating room or hybrid suite under fluoroscopic guidance, intraoperative device testing, wound closure, and post-anesthesia recovery. Post-procedure care includes device interrogation, programming, and scheduled remote monitoring visits. Typical multidisciplinary providers involved are a vascular surgeon or interventional cardiologist for implantation, an anesthesiologist for perioperative management, and device clinic staff or advanced practice providers for follow-up and remote data review. Typical site of service is an ambulatory surgical center or hospital outpatient department; inpatient placement can occur if clinical complexity requires admission.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when intraoperative work or complexity substantially exceeds typical for the implant procedure. |